Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler–Weber–Rendu syndrome (named after the three physicians who first described the condition), is a disease of the blood vessels in the body.
HHT is caused by a genetic abnormality and is inheritable, with a 50 percent chance of passing it on to a child. Approximately 90 percent of patients have an identifiable genetic abnormality through testing.
One of only 18 HHT centers in North America
The Hereditary Hemorrhagic Telangiectasia Center at University of Colorado Hospital is one of only 18 HHT Centers of Excellence in North America.
We offer integrated multidisciplinary care with specialists who are familiar with HHT and who treat different aspects of the disease.
The doctors and staff at University of Colorado Hospital are happy to provide second opinions for patients who have HHT.
- Contact the UCH Cardiac and Vascular Center at (720) 848-5300
- For children, contact Children's Hospital Colorado at (720) 777-6820